When a single contract obligates you to $45 billion over six years, the primary risk is not whether the technology works — it is whether your counterparty survives long enough to deliver. Anthropic's lease with Nscale concentrates enormous operational and financial risk in one relationship, one location, and one chip supplier. That is a concentration profile I would not accept in any portfolio.

The numbers compound concern. Nscale's total Monarch investment is approximately $71 billion, with $47 billion earmarked for AI chips. Anthropic's $45 billion covers the first building only, with remaining capacity starting in 2028. If construction timelines slip — and they routinely do for projects of this scale — Anthropic faces a capacity gap it has already paid for.

I want to highlight the chip dependency specifically. Vera Rubin is an unreleased Nvidia platform. Anthropic is committing to six years of payments on hardware that has no production track record. If Nvidia faces manufacturing delays, yields disappoint, or a successor architecture arrives sooner than expected, the economic value of this lease deteriorates rapidly.

The IPO angle adds a market-timing risk. Nscale could go public as early as next month with $51 billion in contracted revenue. But contracted revenue is not recognized revenue. If Anthropic renegotiates or defaults, that backlog evaporates. Public market investors buying Nscale at IPO are effectively underwriting Anthropic's solvency for the next six years.

Source: TradingKey